Revenue and Profit - The company's revenue for Q1 2025 was CNY 125,285,768.93, a decrease of 32.67% compared to CNY 186,066,748.64 in the same period last year[3] - Net profit attributable to shareholders was CNY 5,406,609.89, down 64.54% from CNY 15,245,888.99 year-on-year[3] - Basic and diluted earnings per share decreased by 62.50% to CNY 0.06 from CNY 0.16 in the same period last year[3] - Total operating revenue for Q1 2025 was ¥125.29 million, a decrease of 32.5% compared to ¥186.07 million in Q1 2024[15] - Net profit for Q1 2025 was ¥13.93 million, a decline of 44.5% from ¥25.06 million in Q1 2024[16] - Operating profit for Q1 2025 was ¥7.13 million, a decrease of 74.8% compared to ¥28.33 million in Q1 2024[15] - The net loss for Q1 2025 was CNY 4,515,291.78, contrasting with a net profit of CNY 54,717.76 in Q1 2024, indicating a substantial decline in profitability[24] Cash Flow - The company reported a net cash flow from operating activities of CNY 30,006,228.97, a significant improvement from a negative cash flow of CNY -22,964,315.87 in the previous year[3] - Cash flow from operating activities for Q1 2025 was ¥30.01 million, a significant improvement from a negative cash flow of ¥22.96 million in Q1 2024[19] - The company's cash and cash equivalents increased significantly to RMB 127,977,012.93 from RMB 43,354,089.88, representing a growth of approximately 195.8%[12] - Cash and cash equivalents at the end of Q1 2025 increased to ¥127.98 million, up from ¥72.01 million at the end of Q1 2024[20] - The company received cash inflows from financing activities totaling ¥145.68 million in Q1 2025, compared to ¥88.50 million in Q1 2024[20] - The company reported a net cash outflow from investing activities of ¥16.95 million in Q1 2025, compared to a net inflow of ¥0.83 million in Q1 2024[20] - The total cash inflow from financing activities in Q1 2025 was ¥139,010,022.76, up from ¥69,150,018.58 in Q1 2024, marking an increase of 100.5%[26] - The net cash flow from financing activities for Q1 2025 was ¥64,974,438.32, compared to ¥26,771,604.27 in Q1 2024, indicating a growth of 142.5%[26] Assets and Liabilities - Total assets increased by 7.56% to CNY 1,367,459,733.42 from CNY 1,271,335,099.56 at the end of the previous year[4] - The company's total assets amounted to RMB 1,367,459,733.42, an increase from RMB 1,271,335,099.56 as of December 31, 2024, reflecting a growth of approximately 7.56%[12] - Total current liabilities decreased to RMB 468,755,097.17 from RMB 520,607,012.36, a reduction of about 9.95%[14] - The company's total liabilities decreased to RMB 591,091,844.33 from RMB 625,634,015.89, a decrease of approximately 5.5%[14] - The company's total liabilities decreased to CNY 422,861,639.98 as of March 31, 2025, down from CNY 440,316,729.98 at the end of 2024, a reduction of approximately 4.0%[22] Shareholder Equity - Shareholders' equity attributable to shareholders rose by 25.02% to CNY 635,699,219.84 from CNY 508,469,683.28 at the end of the previous year[4] - The total owner's equity increased to RMB 776,367,889.09 from RMB 645,701,083.67, reflecting a growth of about 20.24%[14] - The company's equity increased to CNY 600,894,593.14 as of March 31, 2025, compared to CNY 499,498,385.66 at the end of 2024, representing a growth of approximately 20.3%[23] Research and Development - R&D investment totaled CNY 14,540,025.97, a decrease of 13.44% from CNY 16,797,836.89, while the R&D investment as a percentage of revenue increased to 11.61% from 9.03%[4] - Research and development expenses for Q1 2025 were CNY 5,282,419.92, down 29.8% from CNY 7,524,917.08 in Q1 2024[24] Inventory and Receivables - The company's inventory increased to RMB 119,491,807.25 from RMB 106,495,217.47, which is an increase of approximately 12.2%[12] - The company's inventory, which rose to CNY 23,573,977.67 as of March 31, 2025, compared to CNY 11,568,787.46 at the end of 2024, an increase of 103.5%[22] - The accounts receivable decreased slightly to RMB 336,797,843.41 from RMB 343,253,080.11, a decline of about 1.87%[12]
三孚新科(688359) - 2025 Q1 - 季度财报